Now Available, testing for ESR1!

Although extremely rare in primary breast cancers, recent studies suggest that activating mutations in ESR1 are a key mechanism in acquired endocrine resistance in breast cancer therapy.

OncoBEAM™ ESR1 is designed to detect up to 12 different mutations within the ESR1 gene from a single sample and is available as single gene or multigene assays together with AKT1 and PIK3CA.

OncoBEAM™ Mutation Testing

Find your job at Sysmex Inostics
Check out our latest news
Contact Sysmex
Contact us!